Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Florida Man Sues the Makers of Actos, Alleging Drug Caused Bladder Cancer

Filed August 12th, 2013 Laurie

A lawsuit has been filed on behalf of a Florida man who alleges the type 2 diabetes drug Actos caused him to develop bladder cancer. The suit was filed on July 15, 2013, in the U.S. District Court for the Western District of Louisiana, where it is one of thousands of similar cases filed in a multidistrict litigation (MDL). The Plaintiff is being represented by the national law firm Parker Waichman LLP, where founding partner Jerrold S. Parker serves on the Plaintiffs’ Steering Committee in the litigation.

Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants.

According to the complaint, the Plaintiff took Actos from July 2007 to February 2010, when he began to suffer from bladder cancer. In May 2012, the British Medical Journal published a study that revealed that Actos patients were twice as likely to develop bladder cancer. The Canadian Medical Association revealed similar findings in July 2012, when it reported that patients taking Actos were 22 percent more likely to develop bladder cancer. The U.S. Food and Drug Administration (FDA) says that taking the drug for more than one year significantly increases the risk of the disease. The agency changed Actos’ safety label to reflect this information in June 2011. The medication has also been associated with heart problems and eye injuries.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!